Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycled Testosterone in Frail Nursing Home Residents
NCT02679274Phase 1Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Feb 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of testosterone enanthate in frailty syndrome and Sarcopenia, sponsored by The University of Texas Medical Branch at Galveston. Primary endpoint: Change in Fat-free Mass at 10 weeks. Started Feb 2016; status: terminated.
02
Drugs
testosterone enanthate
03
Conditions
frailty syndromeSarcopenia
Beyond the preview
Go deeper on NCT02679274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679274.